(Rac)-ErSO-DFP
Product Specifications
UNSPSC Description
(Rac)-ErSO-DFP is a derivative of ErSO-DFP and a selective small molecule Erα biomodulator. (Rac)-ErSO-DFP againsts ERα+ breast cancer (including resistant tumors) by hyperactiving the Erα-dependent a-UPR (extracted from patent WO2022087234A1)[1].
Target Antigen
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rac-erso-dfp.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(C=CC=C2C1(N3CCC(F)(CC3)F)C4=CC=C(C=C4)O)C(F)(F)F
Molecular Weight
412.35
References & Citations
[1]Hergenrother, et al. Enzyme-activating compounds and compositions. Patent WO2022087234A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-144070A/Rac-ErSO-DFP-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-144070A/
Clinical Information
No Development Reported
CAS Number
2768139-73-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1148947-01 1 mg (E-Coli)
Recombinant Escherichia coli Peptidoglycan synthase FtsI (ftsI), partial
Ask
View Details 
MBS1148947-02 1 mg (Yeast)
Recombinant Escherichia coli Peptidoglycan synthase FtsI (ftsI), partial
Ask
View Details 